PLATO aims to develop a non-invasive molecular diagnostic test based on our patented blood platelet technology to monitor the dynamic mutational status of NSCLC patients for personalised medicine.
Participating countries >THE NETHERLANDS,SWEDEN (bron: www.eurekanetwork.org/project-search)